Publications by authors named "Tim Kahl"

Claim this Profile
T
The Histone Deacetylase Inhibitor Entinostat Mediates HER2 Downregulation in Gastric Cancer, Providing the Basis for Its Particular Efficacy in HER2-Amplified Tumors and in Combination Therapies.
Tamara Zenz, Robert Jenke, René Thieme, Tim Kahl, Hannes Borchardt

Cancer Res Treat· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat.
Tamara Zenz, Robert Jenke, Denys Oliinyk, Sandra Noske, René Thieme, Tim Kahl

Neoplasia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the indirect costs associated with adenocarcinoma or squamous cell carcinoma of the oesophagus in Switzerland: evidence from a cross-sectional survey.
Sandro T Stoffel, Arjun Bhadhuri, Paola Salari, Dieter Koeberle, Thibaud Koessler, Tim Kahl

BMJ Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo.
Michael Karimov, Marion Schulz, Tim Kahl, Sandra Noske, Malgorzata Kubczak

Nanomedicine· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis